Latest News from: Johns Hopkins Medicine

Filters close
Released: 26-Jun-2019 9:00 AM EDT
Factors Orthopaedic Surgeons Should Consider When Prescribing Opioids
Johns Hopkins Medicine

Orthopaedic surgeons are the third-highest physician prescribers of opioids, writing more than 6 million prescriptions a year. Because over-dispensing of opioids is a factor contributing to the ongoing opioid epidemic, researchers at Johns Hopkins surveyed orthopaedic providers to better understand what drives their prescribing practices and to identify gaps in knowledge and potentially worrisome trends. In their survey of 127 orthopaedic providers in the Baltimore area, the Johns Hopkins researchers found that respondents frequently recommended prescribing a nine-day supply of around-the-clock oxycodone doses following commonly performed orthopaedic surgeries. The researchers also found that risk factors that might normally warrant prescribing fewer opioids, such as a history of drug misuse or depression, often did not diminish hypothetical prescribing rates.

Released: 24-Jun-2019 9:00 AM EDT
Physical Evidence In The Brain for Types of Schizophrenia
Johns Hopkins Medicine

In a study using brain tissue from deceased human donors, Johns Hopkins Medicine researchers say they found new evidence that schizophrenia can be marked by the buildup of abnormal proteins similar to those found in the brains of people with such neurodegenerative disorders as Alzheimer’s or Huntington’s diseases.

Released: 18-Jun-2019 10:00 AM EDT
Study Shows Experimental Drug Can Encourage Bone Growth in Children with Dwarfism
Johns Hopkins Medicine

Researchers at Johns Hopkins Medicine, the Murdoch Children’s Research Institute in Australia and seven other medical institutions report that an experimental drug called vosoritide, which interferes with certain proteins that block bone growth, allowed the average annual growth rate to increase in a study of 35 children and teenagers with achondroplasia, a form of dwarfism. The patients’ average boost in height to about 6 centimeters (2.4 inches) per year is close to growth rates among children of average stature, and the side effects of the drug were mostly mild, according to the researchers.

Released: 17-Jun-2019 9:00 AM EDT
Out of Many Ovarian Precancerous Lesions, One Becomes Cancer
Johns Hopkins Medicine

In a novel study of cancer genetics using fallopian tube tissue from 15 women, researchers at the Johns Hopkins Kimmel Cancer Center say they have found evidence that the most common and lethal type of ovarian cancer arises not from a uniform group of precancerous lesions, but from individual growths found in groups genetically unrelated to each other.

Released: 13-Jun-2019 10:00 AM EDT
Study: One-Fifth Of U.S. Surgeons Still ‘Overusing’ Riskier Procedure to Create Kidney Dialysis Access
Johns Hopkins Medicine

Long-term hemodialysis is a lifesaver for approximately half a million patients in the United States with kidney failure (also known as end-stage renal disease, or ESRD) who are either waiting on or unsuitable for a kidney transplant. But before the external machinery can take over the function of the kidneys — filtering and cleansing wastes from the blood — a minor surgical procedure is needed to create a stable, functional and reusable access to the circulatory system, usually through blood vessels in the arm.

Released: 13-Jun-2019 9:00 AM EDT
Implanted Drug ‘Reservoir’ Safely Reduces Injections for People with Macular Degeneration
Johns Hopkins Medicine

In a clinical trial of 220 people with “wet” age-related macular degeneration, Johns Hopkins Medicine researchers, collaborators from many sites across the country, and Genentech in South San Francisco have added to evidence that using a new implant technology that continuously delivers medication into the eyes is safe and effective in helping maintain vision and reduces the need for injections in the eyes.

Released: 12-Jun-2019 1:30 PM EDT
‘Five Star’ Hospitals Often Provide Fewer Services Than Other Hospitals, New Data Suggests
Johns Hopkins Medicine

If you’re looking for a top-notch hospital with a wide range of services, narrowing your list to hospitals with a five-star patient experience rating might lead you astray. Many five-star hospitals offer fewer services than those without five stars, according to a new study by Johns Hopkins researchers published June 10 in JAMA Internal Medicine.

Released: 11-Jun-2019 9:00 AM EDT
Education, Intelligence May Protect Cognition, but Don’t Prevent Alzheimer’s Disease
Johns Hopkins Medicine

In a search for clues to what may delay or prevent Alzheimer’s disease, Johns Hopkins Medicine scientists report that smarter, more educated people aren’t protected from the disease, but do get a cognitive “head start” that may keep their minds functioning better temporarily.

Released: 10-Jun-2019 8:00 AM EDT
How to Improve Care for Patients with Disabilities? We Need More Providers Like Them
Johns Hopkins Medicine

It is common for patients to prefer seeking care from a clinician similar to them — such as of the same gender, ethnicity and culture — who can relate to their experiences and make treatment plans that work better for their lives. To meet these preferences from patients and improve quality of care, a diverse clinician workforce that matches the diversity in the general population is needed. However, when it comes to patients with disabilities, the chance of getting a clinician “like them” is extremely low, which may lead to patients’ reluctance to seek care or follow prescribed interventions and treatments. Meanwhile, without adequate scientists with disabilities bringing perspectives to patient-centered research, the ability to improve care for patients with disabilities is limited.

Released: 30-May-2019 11:00 AM EDT
Newly Discovered Immune Cell Linked to Type 1 Diabetes
Johns Hopkins Medicine

Johns Hopkins Medicine researchers say mysterious, previously unseen “X cell” may be cause of type 1 diabetes

Released: 30-May-2019 8:00 AM EDT
Johns Hopkins Technology That Integrates Earlier Cancer Detection Into Routine Medical Care Receives Record Venture Investment
Johns Hopkins Medicine

A pioneering blood test developed by Johns Hopkins researchers that incorporates earlier cancer detection into routine medical care will be developed by a new company that has raised the largest outside investment ever by a licensee of a Johns Hopkins technology.

28-May-2019 1:00 PM EDT
Media Advisory: May 29 Johns Hopkins Telebriefing to Announce New Blood Test That Can Detect 7 Cancers From Unique Patterns in DNA Fragments
Johns Hopkins Medicine

A telebriefing will announce the development by the Johns Hopkins Kimmel Cancer Center of a new “liquid biopsy” to accurately detect the presence of seven cancers using machine learning, a type of artificial intelligence. The briefing will coincide with the publication of a study in the journal Nature.

28-May-2019 11:00 AM EDT
Johns Hopkins Researchers Design New Blood Test That Uses DNA ‘Packaging’ Patterns to Detect Multiple Cancer Types
Johns Hopkins Medicine

Researchers at the Johns Hopkins Kimmel Cancer Center have developed a simple new blood test that can detect the presence of seven different types of cancer by spotting unique patterns in the fragmentation of DNA shed from cancer cells and circulating in the bloodstream.

Released: 29-May-2019 9:00 AM EDT
Media Alert: Precision Medicine Symposium oo Feature Experts From Across The Nation
Johns Hopkins Medicine

Johns Hopkins inHealth, Johns Hopkins Medicine’s precision medicine effort to tailor health care to the needs of individual patients, is convening nearly two dozen experts from across the nation for a one-day research symposium that will explore ways to improve patient care through precision medicine approaches.

Released: 28-May-2019 10:00 AM EDT
Finding A Cell’s True Identity
Johns Hopkins Medicine

Scientists have long sorted cells into different varieties based on their appearance under a microscope or, for differences that are more visually subtle, based on the behavior of a handful of genes. But in a bid to reveal even more distinctive differences and similarities, researchers from the Johns Hopkins Kimmel Cancer Center, the Johns Hopkins Institute for Genetic Medicine and the Johns Hopkins Department of Neuroscience developed two new artificial intelligence methods that decipher complex gene activity controlling cell fate decisions in retina development and relate this gene activity to what occurs in other tissues and across different species.

Released: 28-May-2019 9:00 AM EDT
Researchers Advance Search For Laboratory Test to Predict Spread of Breast Cancer
Johns Hopkins Medicine

Researchers at The Johns Hopkins University and other institutions report that a new laboratory test that induces cancer cells to squeeze through narrow spaces has the potential to accurately predict which breast cancers and other solid tumors are likely to spread, or metastasize, to other sites. The test, they say, might also help clinicians select the best drugs to prevent cancer’s spread.

Released: 28-May-2019 8:00 AM EDT
New Evidence Supports Surgery For Rare Type of Brain Lymphoma
Johns Hopkins Medicine

Through a systematic review of published studies going back 50 years, Johns Hopkins Medicine researchers say they have identified a distinct subtype of primary central nervous system (PCNS) lymphoma that should be considered for surgical removal, suggesting a major shift in how this type of tumor is evaluated and managed.

Released: 23-May-2019 9:00 AM EDT
Website For Women With Diabetes Engages Patient Sharing, Guides Research
Johns Hopkins Medicine

Johns Hopkins Medicine researchers created an online patient community for women living with all types of diabetes to test whether online communities can engage patients and provide information that can guide research and patient care. The researchers found that the majority of women who joined the online community used it at least occasionally to ask or respond to questions and ideas about research as well as patient care.

20-May-2019 9:00 AM EDT
A Road Map to Stem Cell Development
Johns Hopkins Medicine

Johns Hopkins Medicine researchers report they have created a method of mapping how the central nervous system develops by tracking the genes expressed in cells. The technique, demonstrated in mouse retinas for this study, follows the activity of the genes used by individual cells during development, allowing researchers to identify patterns in unprecedented detail. This precise kind of road map, say the researchers, could be used to develop future regenerative treatments for blinding and other neurological diseases

Released: 21-May-2019 9:00 AM EDT
Johns Hopkins Researchers Publish Digital Health Roadmap
Johns Hopkins Medicine

In the dizzying swirl of health-related websites, social media and smartphone apps, finding a reliable source of health information can be a challenge. A group of researchers from the Johns Hopkins University schools of medicine and public health, as well as the university’s Applied Physics Laboratory, have mapped out a course to navigate that complicated landscape.

Released: 21-May-2019 8:00 AM EDT
Tip Sheet: Recent Research on How DNA is Read and Copied
Johns Hopkins Medicine

Two scientists at the Johns Hopkins University School of Medicine have unraveled aspects of how DNA organizes and preserves genetic information. Newly published research by Cynthia Wolberger, Ph.D., and James Berger, Ph.D., whose labs sit side by side, takes a closer look at how the puzzle pieces of DNA machinery fit together.

Released: 20-May-2019 8:00 AM EDT
Key Acid-Activated Protein Channel Identified
Johns Hopkins Medicine

Johns Hopkins researchers have discovered a long-sought protein, the proton-activated chloride channel (PAC), that is activated in acidic environments and could protect against the tissue-damaging effects of stroke, heart attack, cancer and inflammation. The researchers believe the discovery of this protein could provide a new drug target for potential therapies for stroke and other health issues.

Released: 16-May-2019 9:00 AM EDT
Research Suggests Revision to Common View on How Retinal Cells in Mammals Process Light
Johns Hopkins Medicine

Johns Hopkins Medicine scientists say that new experiments with mouse eye tissues strongly suggest that a longstanding “textbook concept” about the way a mammal’s retina processes light needs a rewrite.

13-May-2019 11:00 AM EDT
Hopkins-Led Team Finds Biomarkers to Diagnose Serious Kidney Allergic Reaction
Johns Hopkins Medicine

A team led by Johns Hopkins Medicine researchers says it has identified two protein biomarkers in urine that may one day be used to better diagnose acute interstitial nephritis (AIN), an underdiagnosed but treatable kidney disorder that impairs renal function in the short term and can lead to chronic kidney disease, permanent damage or renal failure if left unchecked.

Released: 15-May-2019 11:00 AM EDT
Feeling Healthy: A Good Start, But Not Always A Good Indicator of Heart Disease Risk
Johns Hopkins Medicine

Most people feel they have a general idea of how healthy they are based on their diet and exercise regimen and how often they get sick. But a new study by Johns Hopkins Medicine researchers adds to evidence that how healthy people think they are isn’t always an accurate indicator of their risk for cardiovascular disease.

Released: 15-May-2019 10:00 AM EDT
Membrane Madness: The Ins and Outs of Moving Materials Through the Cell
Johns Hopkins Medicine

The cell membrane is a fatty layer that forms a border between the inside of the cell, its various structures and the outside world. Embedded in these layers of fat, like tiles in a mosaic, are proteins that allow the cell to communicate with its neighbors, remove waste, regulate its composition and create energy.

Released: 15-May-2019 9:00 AM EDT
On The Way to Fighting Staph Infections With The Body’s Immune System
Johns Hopkins Medicine

Researchers have gained a greater understanding of the biology of staphylococcus skin infections in mice and how the mouse immune system mobilizes to fight them. A study appears this week in the Proceedings of the National Academy of Sciences of the United States of America. Community acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) typically causes skin infections but can spread throughout the body to cause invasive infections such as sepsis, and possibly death.

Released: 15-May-2019 8:00 AM EDT
Johns Hopkins Researchers Find Widely “Inconsistent” Use of Antibodies in Lab Experiments
Johns Hopkins Medicine

Scientists at the Johns Hopkins Kimmel Center say they have affirmed widespread inconsistencies in the use of a common laboratory procedure called immunohistochemical staining, and say the variations are making many laboratory experiments unreliable.

Released: 14-May-2019 10:00 AM EDT
Brain Changes Linked With Alzheimer’s Years Before Symptoms Appear
Johns Hopkins Medicine

**Note to journalists: Michael Miller, Ph.D., will discuss this research at the Johns Hopkins Science Writers’ Boot Camp on June 10 at the National Press Club in Washington, D.C. Learn more and register for the free, daylong immersion in topics about mental health and addiction.

Released: 14-May-2019 9:00 AM EDT
Earlier, More Frequent Removal of Some Pancreatic Cysts May Decrease Cancer Risk for Some Patients
Johns Hopkins Medicine

By analyzing medical records of 901 adults who had surgery for a certain type of precancerous pancreatic cyst, researchers at Johns Hopkins Medicine and The Karolinska Institute in Sweden have updated parameters for an anatomical “marker” that can tell more precisely if these cysts are likely to develop into lethal pancreatic cancers.

Released: 13-May-2019 12:00 PM EDT
When Possible, Upper and Lower GI Endoscopies Should Be Done on Same Day
Johns Hopkins Medicine

If your car needs work on its front and rear axles, it’s obviously more convenient, efficient and cost effective to have both repairs done at the same time. Now, researchers at Johns Hopkins Medicine have shown similar benefits from “bundling” upper and lower gastrointestinal endoscopies on the same day to remedy what they say is the “disturbingly” large number of older Americans currently being scheduled for the procedures on two different days.

Released: 8-May-2019 9:00 AM EDT
Broccoli Sprout Compound May Restore Brain Chemistry Imbalance Linked to Schizophrenia
Johns Hopkins Medicine

In a series of recently published studies using animals and people, Johns Hopkins Medicine researchers say they have further characterized a set of chemical imbalances in the brains of people with schizophrenia related to the chemical glutamate. And they figured out how to tweak the level using a compound derived from broccoli sprouts.

Released: 7-May-2019 10:00 AM EDT
Stem Cells Make More ‘Cargo’ Packets to Carry Cellular Aging Therapies
Johns Hopkins Medicine

Johns Hopkins scientists report that adult cells reprogrammed to become primitive stem cells, called induced pluripotent stem cells (iPSCs), make tiny “cargo packets” able to deliver potentially restorative or repairing proteins, antibodies or other therapies to aged cells. They say the human iPSCs they studied produced much more of the packets, formally known as extracellular vesicles, than other kinds of adult stem cells commonly used for this purpose in research.

Released: 7-May-2019 9:00 AM EDT
Tumor Mutations May Predict Response to Immunotherapy
Johns Hopkins Medicine

Checkpoint inhibitor drugs that stimulate the immune system have become a growing success story in the treatment of some cancers. But about half of patients whose tumors are marked by a large number of mutations from so-called mismatch repair genetic deficiency fail to respond to the drugs.

Released: 6-May-2019 11:00 AM EDT
Tip Sheet: Studies On Opioid-Prescribing Practices
Johns Hopkins Medicine

Although opioids play a key role in reducing pain when recovering from surgery, some patients transition to chronic users and become dependent on them. In order to find out what situations result in patients continuing to refill their opioid prescriptions after a surgery, Johns Hopkins researchers scoured a database of more than 900,000 people who had a surgery scheduled and were prescribed opioids for the first time.

Released: 6-May-2019 10:00 AM EDT
‘Google Maps’ for Cancer: Image-Based Computer Model Reveals Finer Details of Tumor Blood Flow Behavior
Johns Hopkins Medicine

Johns Hopkins Medicine researchers say they have developed something akin to a “Google Maps” approach for more accurately computing and visualizing the structural and functional blood vessel changes needed for tumor growth. By pairing high-quality 3D imaging data of tumor specimens from animal models with sophisticated mathematical formulas, the researchers say they now have a model that accurately represents blood traffic inside tumors, including the complex blood flow, oxygenation and structural changes that occur.

Released: 6-May-2019 9:00 AM EDT
Rheumatoid Arthritis Drug Diminishes Zika Birth Defects in Mice
Johns Hopkins Medicine

In experiments with pregnant mice infected with the Zika virus, Johns Hopkins Medicine researchers report they have successfully used a long-standing immunosuppressive drug to diminish the rate of fetal deaths and birth defects in the mice’s offspring.

2-May-2019 1:00 PM EDT
Excessive Use of Skin Cancer Surgery Curbed With Awareness Effort
Johns Hopkins Medicine

Sometimes a little gentle peer persuasion goes a long way toward correcting a large problem. That’s the message from researchers at Johns Hopkins Medicine and seven collaborating health care organizations which report that a “Dear Colleague” performance evaluation letter successively convinced physicians nationwide to reduce the amount of tissue they removed in a common surgical treatment for skin cancer to meet a professionally recognized benchmark of good practice.

Released: 2-May-2019 9:00 AM EDT
Johns Hopkins Researchers Develop Soft Tissue Substitute With Fewer Side Effects
Johns Hopkins Medicine

A team of plastic surgeons and material scientists has made an important advance in treating the common clinical problem of soft tissue loss. They have invented a synthetic soft tissue substitute that is well tolerated and encourages the growth of soft tissue and blood vessels. This new material retains its shape without being too dense, overcoming challenges with current tissue fillers that tend to be either too soft or not porous enough to let cells move in and start regrowing tissue. A report on this work appears today in Science Translational Medicine.

29-Apr-2019 9:00 AM EDT
Mouse Studies Show Minimally Invasive Route Can Accurately Administer Drugs to Brain
Johns Hopkins Medicine

In experiments in mice, Johns Hopkins researchers say they have developed a technique that facilitates the precise placement of cancer drugs at their intended targets in the brain. This approach pairs a technique that guides a catheter through the brain’s arteries with positron emission technology (PET) scans to precisely place cancer drugs at their intended targets in the brain. If future studies show this image-guided drug delivery method is safe and effective in humans, the researchers say it could improve outcomes for historically difficult-to-treat and often lethal brain cancers, such as glioblastoma.

Released: 1-May-2019 9:00 AM EDT
Restoring Brain Function in Mice with Symptoms of Alzheimer’s Disease
Johns Hopkins Medicine

A study in mice shows that selectively removing cells that are no longer dividing from the brains of mice with a form of Alzheimer’s disease can reduce brain damage and inflammation, and slow the pace of cognitive decline. These findings, say researchers, add to evidence that such senescent cells contribute to the damage caused by Alzheimer’s disease in people.

Released: 30-Apr-2019 2:00 PM EDT
Johns Hopkins Structural Biologist Among 125 Elected to National Academy of Sciences
Johns Hopkins Medicine

Cynthia Wolberger, Ph.D., a structural biologist who unravels how cells use chemical tags to turn genes on and off, is among 125 scientists newly elected to the National Academy of Sciences.

Released: 25-Apr-2019 10:00 AM EDT
Alcohol Relapse Rate Among Liver Transplant Recipients Identical Whether or Not There is A 6-Month Wait Before Transplant
Johns Hopkins Medicine

Alcohol Relapse Rate Among Liver Transplant Recipients Identical Whether or Not There is A 6-Month Wait Before Transplant 04/25/2019 AddThis Sharing Buttons Share to Facebook Share to TwitterShare to EmailShare to PrintShare to More Credit: Getty Images For decades, patients with liver disease related to alcohol use have been told they must be sober for six months before they can get a liver transplant. Many die before that six-month wait period is up. Now, a growing number of researchers are questioning that six-month waiting period.

Released: 25-Apr-2019 9:00 AM EDT
Few At-Risk Adults Getting the Diabetes Prevention Help They Need
Johns Hopkins Medicine

Using data from the 2016 National Health Interview Survey, Johns Hopkins researchers report that few American adults eligible for diabetes prevention programs are being referred to, or participating in, these programs.

Released: 24-Apr-2019 11:00 AM EDT
Hopkins Researchers ID Neurotransmitter That Helps Cancers Progress
Johns Hopkins Medicine

Using human cancer cells, tumor and blood samples from cancer patients, researchers at Johns Hopkins Medicine have uncovered the role of a neurotransmitter in the spread of aggressive cancers. Neurotransmitters are chemical “messengers” that transmit impulses from neurons to other target cells.

Released: 24-Apr-2019 10:00 AM EDT
Tip Sheet: Studies on Obesity, Opioids And Vaccines Among Hopkins Research to Be Presented at National Pediatrics Meeting
Johns Hopkins Medicine

What: Pediatric Academic Societies (PAS) 2019 Meeting When: April 27-30, 2019 Where: Baltimore Convention Center (1 W. Pratt St, Baltimore, Maryland 21201)

Released: 23-Apr-2019 2:00 PM EDT
Experiences of ‘Ultimate Reality’ or ‘God’ Confer Lasting Benefits to Mental Health
Johns Hopkins Medicine

People over the millennia have reported having deeply moving religious experiences either spontaneously or while under the influence of psychedelic substances such as psilocybin-containing mushrooms or the Amazonian brew ayahuasca, and a portion of those experiences have been encounters with what the person regards as “God” or “ultimate reality.” In a survey of thousands of people who reported having experienced personal encounters with God, Johns Hopkins researchers report that more than two-thirds of self-identified atheists shed that label after their encounter, regardless of whether it was spontaneous or while taking a psychedelic.

Released: 23-Apr-2019 9:00 AM EDT
Number of Women Who Aren't Physically Active Enough is High And Growing
Johns Hopkins Medicine

Using data from a national survey representing more than 19 million U.S. women with established cardiovascular disease, Johns Hopkins Medicine researchers say that more than half of women with the condition do not do enough physical activity and those numbers have grown over the last decade. These results imply that targeted counseling to exercise more could reduce risk of cardiovascular disease as well as associated health care costs over their lifetimes.

Released: 23-Apr-2019 9:00 AM EDT
Pre-Op Daily Life Disability May Predict Poor Outcome After Hip Replacement
Johns Hopkins Medicine

A new Johns Hopkins Medicine study looking at medical records of more than 43,000 U.S. adults with hip-joint damaging osteoarthritis suggests that those who cannot perform daily activities independently before total hip replacement surgery are more likely to have poorer outcomes after surgery.

Released: 22-Apr-2019 9:00 AM EDT
Study Suggests Overdiagnosis of Schizophrenia
Johns Hopkins Medicine

In a small study of patients referred to the Johns Hopkins Early Psychosis Intervention Clinic (EPIC), Johns Hopkins Medicine researchers report that about half the people referred to the clinic with a schizophrenia diagnosis didn’t actually have schizophrenia. Schizophrenia is a chronic, severe and disabling disorder marked by disordered thinking, feelings and behavior. People who reported hearing voices or having anxiety were the ones more likely to be misdiagnosed.



close
1.07294